In the last recent years, the association between low serum levels of A1AT and the development of RA has been identified, particularly in relation to specific A1AT genotypes
Docking and MD studies further enable the rational design of pathogen-responsive linkers for ID-ADCs by modeling interactions with pathogen proteases such as Leishmania GP63 while minimizing off-target cleavage by host enzymes ( 8.4 QSAR/QSPR and docking for payload optimization QSAR and QSPR modeling correlate physicochemical and quantum-derived descriptors of antimicrobial and metallo-drug payloads with biological activity and cytotoxicity, guiding iterative payload refinement for ID-ADC (Lu et al., 2022)
Vitamin B12 There is four types of parenteral Vitamin B12 available: Cyanocobalamin 100 mcg/ml and 1000 mcg/ml best used as IM to prevent rapid loss via kidneys Hydroxycobalamin IM (compounded 1000 mcg/ml or more) known as long acting B12 (binds better to plasma proteins than cyanocobalamin) Methylcobalamin IV (compounded 1000 mcg or more up to 5000 mcg/ml) Adenosylcobalamin IV Common dose is 1000 mcg IM or IV Vitamin B12 as hydroxycobalamin is synthesized exclusively by microorganisms and is found in the liver of animals bound to protein as methylcobalamin = metabolically active form of Vitamin B12 Hydroxycobalamin is a chelator of cyanide and is used in cyanide poisoning Hydroxocobalamin is most generally used for vitamin B12 replacement therapy and is considered the drug of choice for vitamin B12 deficiency by the Martindale Extra Pharmacopoeia (Sweetman, 2002) and the World Health Organization (WHO) Model List of Essential Drugs
Archives of Toxicology
6B showed that the average fluorescence intensity of inhaled DID@M in the lungs surpassed that of DID@Lipo, being 1.41-fold, 2.38-fold, 2.24-fold, and 3.12-fold higher at 6 h, 12 h, 24 h, and 48 h, respectively, and surpassed that of injected DID@M, being 48.30-fold, 70.32-fold, 44.09-fold, and 52.87-fold higher at 6 h, 12 h, 24 h, and 48 h, respectively
